First CAR T-cell therapy recommended on NHS
NICE’s recommendation of Yescarta® means it is the first time…
NICE’s recommendation of Yescarta® means it is the first time patients will be able to access CAR T-cell therapy long-term on the NHS.
List view / Grid view
NICE’s recommendation of Yescarta® means it is the first time…
NICE’s recommendation of Yescarta® means it is the first time patients will be able to access CAR T-cell therapy long-term on the NHS.
With the Association of the British Pharmaceutical Industry (ABPI), Gilead…
With the Association of the British Pharmaceutical Industry (ABPI), Gilead Sciences will work to tackle health crises and shape international trade and regulation.